GB002 Recombinant Peptide Inhalation Solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GB002 Recombinant Peptide Inhalation Solution, covering 2025-04-09 to 2025-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects [Phase 1]